ZVSA

ZyVersa Therapeutics
ZVSA

Overview Fund Activity
Delisted

ZVSA was delisted on the 16th of July, 2025.

Back to rankings

24 hedge funds and large institutions have $62.2M invested in ZyVersa Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
6
Increased
5
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PC
Periscope Capital
Ontario, Canada
$2.9M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
$3.84M
3
Barclays
Barclays
United Kingdom
$1.38M
4
SCM
Saba Capital Management
New York
$5.8M
5
CSS
Cubist Systematic Strategies
Connecticut
$521K

Top Sellers

1
MSU
Mizuho Securities USA
New York
$0
2
FLC
Fifth Lane Capital
Texas
$0
3
CCM
Context Capital Management
California
$4.91M
4
AA
AQR Arbitrage
Connecticut
$1.82M
5
KIM
Karpus Investment Management
New York
$429K
Name Holding Trade Value Shares
Change 		Shares
Change %
SCC
26
Spring Creek Capital
Kansas
– -$3.47M -1,000 Closed
MSU
27
Mizuho Securities USA
New York
– -$1.83M -529 Closed
FLC
28
Fifth Lane Capital
Texas
– -$496K -143 Closed
1
2